Hayden B - Search Results

1

Ocular aspirin distribution: a comparison of intravenous, topical, and coulomb-controlled iontophoresis administration.

Voigt M, Kralinger M, Kieselbach G, Chapon P, Anagnoste S, Hayden B, Parel JM. Voigt M, et al. Among authors: hayden b. Invest Ophthalmol Vis Sci. 2002 Oct;43(10):3299-306. Invest Ophthalmol Vis Sci. 2002. PMID: 12356838

2

Iontophoretic delivery of carboplatin in a murine model of retinoblastoma.

Hayden B, Jockovich ME, Murray TG, Kralinger MT, Voigt M, Hernandez E, Feuer W, Parel JM. Hayden B, et al. Invest Ophthalmol Vis Sci. 2006 Sep;47(9):3717-21. doi: 10.1167/iovs.06-0365. Invest Ophthalmol Vis Sci. 2006. PMID: 16936078

3

Pharmacokinetics of systemic versus focal Carboplatin chemotherapy in the rabbit eye: possible implication in the treatment of retinoblastoma.

Hayden BC, Jockovich ME, Murray TG, Voigt M, Milne P, Kralinger M, Feuer WJ, Hernandez E, Parel JM. Hayden BC, et al. Invest Ophthalmol Vis Sci. 2004 Oct;45(10):3644-9. doi: 10.1167/iovs.04-0228. Invest Ophthalmol Vis Sci. 2004. PMID: 15452072

4

Experimental model for proliferative vitreoretinopathy by intravitreal dispase: limited by zonulolysis and cataract.

Kralinger MT, Kieselbach GF, Voigt M, Hayden B, Hernandez E, Fernandez V, Parel JM. Kralinger MT, et al. Among authors: hayden b. Ophthalmologica. 2006;220(4):211-6. doi: 10.1159/000093073. Ophthalmologica. 2006. PMID: 16785750

5

Combretastatin A-4 prodrug in the treatment of a murine model of retinoblastoma.

Escalona-Benz E, Jockovich ME, Murray TG, Hayden B, Hernandez E, Feuer W, Windle JJ. Escalona-Benz E, et al. Among authors: hayden b. Invest Ophthalmol Vis Sci. 2005 Jan;46(1):8-11. doi: 10.1167/iovs.04-0751. Invest Ophthalmol Vis Sci. 2005. PMID: 15623747

6

Mechanism of retinoblastoma tumor cell death after focal chemotherapy, radiation, and vascular targeting therapy in a mouse model.

Jockovich ME, Suarez F, Alegret A, Piña Y, Hayden B, Cebulla C, Feuer W, Murray TG. Jockovich ME, et al. Among authors: hayden b. Invest Ophthalmol Vis Sci. 2007 Dec;48(12):5371-6. doi: 10.1167/iovs.07-0708. Invest Ophthalmol Vis Sci. 2007. PMID: 18055783

7

Magnetically integrated microporous implant: safety and efficacy of secondary posting.

Escalona-Benz E, Benz MS, Murray TG, Hayden BC, Hernandez E, Garonzik SN, Cicciarelli NL. Escalona-Benz E, et al. Arch Ophthalmol. 2003 Nov;121(11):1596-600. doi: 10.1001/archopht.121.11.1596. Arch Ophthalmol. 2003. PMID: 14609918

8

Hyperfractionated external beam radiation therapy in the treatment of murine transgenic retinoblastoma.

Hayden BC, Murray TG, Cicciarelli N, Scott IU, Alexandridou A, Hernandez E, Wu X, Markoe AM, Feuer W, Fulton L, O'Brien JM. Hayden BC, et al. Arch Ophthalmol. 2002 Mar;120(3):353-9. doi: 10.1001/archopht.120.3.353. Arch Ophthalmol. 2002. PMID: 11879140

9

Comparison of retinoblastoma reduction for chemotherapy vs external beam radiotherapy.

Sussman DA, Escalona-Benz E, Benz MS, Hayden BC, Feuer W, Cicciarelli N, Toledano S, Markoe A, Murray TG. Sussman DA, et al. Arch Ophthalmol. 2003 Jul;121(7):979-84. doi: 10.1001/archopht.121.7.979. Arch Ophthalmol. 2003. PMID: 12860801

10

External beam radiation "salvage" therapy in transgenic murine retinoblastoma.

Sobrin L, Hayden BC, Murray TG, Cicciarelli N, Scott IU, Hernandez E, Wu X, Markoe AM, Feuer W, Fulton L, O'Brien JM. Sobrin L, et al. Arch Ophthalmol. 2004 Feb;122(2):251-7. doi: 10.1001/archopht.122.2.251. Arch Ophthalmol. 2004. PMID: 14769602

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

326 results

Search Page

Filters